Florian Umstätter

Vancomycin-Lipopeptide Conjugates with High Antimicrobial Activity on Vancomycin-Resistant Enterococci

U. Haberkorn, K. Ohlsen, W. Mier, 2020, Pharmaceuticals.

Replacement of l-Amino Acids by d-Amino Acids in the Antimicrobial Peptide Ranalexin and Its Consequences for Antimicrobial Activity and Biodistribution

M. Wink, W. Mier, K. Leotta, 2019, Molecules.

Renaissance of Vancomycin: Approaches for Breaking Antibiotic-Resistance in Multidrug-Resistant Bacteria.

W. Mier, C. Kleist, P. Uhl, 2019, Canadian journal of microbiology.

Vancomycin Resistance Is Overcome by Conjugation of Polycationic Peptides

U. Haberkorn, K. Ohlsen, W. Mier, 2020, Angewandte Chemie.

Fatty Acid Conjugation Leads to Length-Dependent Antimicrobial Activity of a Synthetic Antibacterial Peptide (Pep19-4LF)

U. Haberkorn, K. Brandenburg, W. Mier, 2020, Antibiotics.

Impact of Linker Modification and PEGylation of Vancomycin Conjugates on Structure-Activity Relationships and Pharmacokinetics

U. Haberkorn, K. Ohlsen, W. Mier, 2022, Pharmaceuticals.

Trends in liposomal nanocarrier strategies for the oral delivery of biologics.

W. Mier, G. Fricker, P. Uhl, 2021, Nanomedicine.

Improved pharmacokinetics and enhanced efficacy of the vancomycin derivative FU002 using a liposomal nanocarrier.

K. Ohlsen, B. Beijer, T. Hertlein, 2023, Nanomedicine : nanotechnology, biology, and medicine.